3
项与 Birch pollen allergy immunotherapy(LETI Pharma GmbH) 相关的临床试验Multicenter, placebo-controlled, long-term study of Depigoid Birch 5000 in adults and adolescents with allergic rhinitis and/or rhinoconjunctivitis with or without intermittent asthma - Depigoid Birch
Multicenter, Placebo-controlled, Long-term Study of Depigoid Birch 5000 in Adults and Adolescents With Allergic Rhinitis and/or Rhinoconjunctivitis With or Without Intermittent Asthma
Specific immunotherapy for IgE mediated sensitization to birch pollen. Long-term study to assess safety and efficacy of Depigoid(R)Birch 5000 - a modified pollen extract of Betula alba (Birch) - versus placebo.
Multicenter, placebo-controlled, long-term study of Depigoid Birch 5000 in adults and adolescents with allergic rhinitis and/or rhinoconjunctivitis with or without intermittent asthma - Depigoid Birch
100 项与 Birch pollen allergy immunotherapy(LETI Pharma GmbH) 相关的临床结果
100 项与 Birch pollen allergy immunotherapy(LETI Pharma GmbH) 相关的转化医学
100 项与 Birch pollen allergy immunotherapy(LETI Pharma GmbH) 相关的专利(医药)
100 项与 Birch pollen allergy immunotherapy(LETI Pharma GmbH) 相关的药物交易